Fundraising FoxDan Janney
InvestorManaging Director at Alta Partners
San Francisco, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Dan
Sign up to see every warm intro you have to Dan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Dan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Dan Janney is Managing Partner of Alta Partners, which he joined at its founding in 1996. He has over 25 years of early-stage life sciences investing experience, focused on building companies around new biology insights and drug discovery approaches, and has helped fund and develop more than 45 companies. Before Alta, he was a senior investment banker at Montgomery Securities, and he holds a B.A. from Georgetown University and an MBA from UCLA's Anderson School.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 6
Allakos IncBoard seat
via Alta Partners · filed Dec 2017 · $100.1M raise
Krystal BiotechBoard seat
via Alta Partners · filed Aug 2017 · $11.3M raise
ProlactaBoard seat
via Alta Partners · filed Dec 2016 · $35M raise
Esperion TherapeuticsLed round
via Alta Partners · filed Jun 2014
CoTherixLed round
via Alta Partners
ILEX OncologyLed round
via Alta Partners
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Astex PharmaceuticalsCellectiveChemGenexDefinity HealthDynavaxEndoneticsInterMuneLJL BiosystemsMako SurgicalProlacta BioscienceTriangle Pharmaceuticals
Board seats
BE BiopharmaDEM BioPharmaEdgewood Oncology, Inc.Lassen TherapeuticsProgentos Therapeutics
Investor
ChemGenex PharmaceuticalsDEM BioPharmaEdgewood OncologyEsperionEvofem BiosciencesImmuneIDLassen TherapeuticsNovome BiotechnologiesProgentos TherapeuticsVirobay
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Alta Partners
Network5
Investors connected to Dan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dan Janney?
- Dan Janney is Managing Partner of Alta Partners, which he joined at its founding in 1996. He has over 25 years of early-stage life sciences investing experience, focused on building companies around new biology insights and drug discovery approaches, and has helped fund and develop more than 45 companies. Before Alta, he was a senior investment banker at Montgomery Securities, and he holds a B.A. from Georgetown University and an MBA from UCLA's Anderson School.
- Where does Dan Janney work?
- Dan Janney is Managing Director at Alta Partners.
- What does Dan Janney invest in?
- Dan Janney invests in Biotech.
- What check size does Dan Janney write?
- Dan Janney typically writes checks of $100K – $5M.
- What boards does Dan Janney sit on?
- Dan Janney holds tracked board seats at Allakos Inc, BE Biopharma, DEM BioPharma, Edgewood Oncology, Inc., Krystal Biotech, Krystal Biotech, Lassen Therapeutics, Progentos Therapeutics, Prolacta.
- What companies has Dan Janney invested in?
- Investments tracked here include Allakos Inc, Astex Pharmaceuticals, Cellective, ChemGenex, CoTherix, Definity Health, Dynavax, Endonetics, Esperion Therapeutics, ILEX Oncology, InterMune, LJL Biosystems, and 13 more.
- Does Dan Janney lead rounds?
- Yes — Dan Janney has led 15 tracked investments.
About this profile. Compiled from public sources — Alta Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights